Prevalence, Extent, and Independent Predictors of Silent Myocardial Infarction Nisha Arenja, MD, Christian Mueller, MD, Niklas F. Ehl, MD, Miriam Brinkert, MD, Katharina Roost, MD, Tobias Reichlin, MD, Seoung Mann Sou, MD, Thomas Hochgruber, MD, Stefan Osswald, MD, Michael J. Zellweger, MD The American Journal of Medicine Volume 126, Issue 6, Pages 515-522 (June 2013) DOI: 10.1016/j.amjmed.2012.11.028 Copyright © 2013 Elsevier Inc. Terms and Conditions
Figure 1 (A) Composition of the derivation cohort → including incomplete myocardial perfusion single photon emission computed tomography scan. (B) Composition of the validation group. MI = myocardial infarction; MPS = myocardial perfusion single photon emission computed tomography. The American Journal of Medicine 2013 126, 515-522DOI: (10.1016/j.amjmed.2012.11.028) Copyright © 2013 Elsevier Inc. Terms and Conditions
Figure 2 Percentage of silent myocardial infarction in diabetics and nondiabetics in the derivation and the validation cohort. The American Journal of Medicine 2013 126, 515-522DOI: (10.1016/j.amjmed.2012.11.028) Copyright © 2013 Elsevier Inc. Terms and Conditions